Showing results (591-600 of 622) with videos related to

Sort By:
Pageof 63
Journal of Neuromuscular Diseases|April 12, 2024
Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular DystrophyCraig M Zaidman, Natalie L Goedeker, Amal A Aqul, et al.
Drug Safety|November 9, 2013
Anti-tuberculosis drug-induced liver injury in Shanghai: validation of Hy's LawXin Shen, Zheng'an Yuan, Jian Mei, et al.
Clinical and Experimental Immunology|November 25, 2014
Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitisD M Foureau, T L Walling, V Maddukuri, et al.
BMC Plant Biology|April 23, 2017
Delayed response to cold stress is characterized by successive metabolic shifts culminating in apple fruit peel necrosisNigel E Gapper, Maarten L A T M Hertog, Jinwook Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2007
Blood gene expression signatures predict exposure levelsP R Bushel, A N Heinloth, J Li, et al.
Nature Genetics|March 30, 2001
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expressionP Kuehl, J Zhang, Y Lin, et al.
Clinical Pharmacology in Drug Development|January 19, 2026
A Phase 1 Dose-Escalation, Food Effect, and Drug-Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR-1505, in Healthy VolunteersVipul K Gupta, Brian Yoo, Daniel Weiss, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 9, 2016
The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus MacaquesH B Zheng, B Watkins, V Tkachev, et al.
Clinical Pharmacology and Therapeutics|November 2, 2020
Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug RegimensPaola Nicoletti, Harshad Devarbhavi, Ashish Goel, et al.
ALTEX|January 24, 2023
Incorporating new approach methodologies into regulatory nonclinical pharmaceutical safety assessmentJan Turner, Pandora Pound, Carla Owen, et al.
Pageof 63